CIK 0001178670 · Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770602661
- Phone
- (617) 551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-12 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −14 | $374.44 | $5K | 23,588 |
| 2026-01-12 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −19 | $375.65 | $7K | 23,569 |
| 2026-01-12 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −15 | $377.82 | $6K | 23,554 |
| 2026-01-11 | Garg Pushkal EVP Chief R&D | Grant or award | +3,800 | 24,021 | ||
| 2026-01-11 | Greenstreet Yvonne Chief Executive Officer | Grant or award | +19,003 | 87,988 | ||
| 2026-01-11 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award | +6,193 | 60,245 | ||
| 2026-01-11 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award | +3,800 | 31,238 | ||
| 2026-01-11 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Grant or award 10b5-1 | +3,800 | 25,064 | ||
| 2026-01-05 | Arbuckle Stuart A Director | Grant or award · Stock Option (right to buy) | +3,279 | 3,279 | ||
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise | +839 | $119.13 | $100K | 66,248 |
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise | +2,352 | $85.00 | $200K | 68,600 |
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise | +847 | $118.05 | $100K | 69,447 |
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise | +659 | $151.59 | $100K | 70,106 |
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Shares withheld for taxes | −1,121 | $445.12 | $499K | 68,985 |
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) | −2,352 | 0 | ||
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) | −847 | 0 | ||
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) | −839 | 0 | ||
| 2025-11-26 | Greenstreet Yvonne Chief Executive Officer | Option exercise · Stock Option (right to buy) | −659 | 28,141 | ||
| 2025-11-17 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Option exercise 10b5-1 | +8,161 | $119.13 | $972K | 33,392 |
| 2025-11-17 | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | Sale 10b5-1 | −8,168 | $449.00 | $3.7M | 25,224 |
Page 16 of 41 · 816 trades